Pearl River Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,724	Closed	-$242K	–	622
2019 Q4	$242K	Buy	+3,724	New	+$242K	0.09%	411
2019 Q1	–	Sell	-481	Closed	-$41K	–	585
2018 Q4	$41K	Buy	+481	New	+$41K	0.19%	147